Claims
- 1. A method of suppressing a human immune response to an antigen which comprises administering to the human an immunosuppressively effective amount of antigen non-specific human GIF, glycosylation inhibiting factor, having a molecular weight of 13 kD as determined by reducing SDS-PAGE and a sequence as set forth in SEQ ID NO:38.
- 2. The method of claim 1, wherein the administration is parenteral.
- 3. The method of claim 2, wherein the parenteral administration is by subcutaneous, intramuscular, intraperitoneal, intracavity, transdermal, or intravenous injection.
- 4. The method of claim 1, wherein the administration is at a dosage of 0.001 mg/kg/dose to 2 mg/kg/dose.
- 5. The method of claim 1, wherein the administration is at a dosage of 0.001 mg/kg/dose to 0.2 mg/kg/dose.
Parent Case Info
This application is a divisional application of Ser. No. 08/061,041, filed May 14, 1993, now abandoned which is a continuation-in-part of PCT/US92/04614, filed Jun. 3, 1992, which is a continuation-in-part of U.S. Pat. No. 709,375, filed Jun. 3, 1991, now abandoned, which is a continuation-in-part of Ser. No. 533,889, now abandoned, filed Jun. 4, 1990.
Government Interests
This invention was made with Government support under grant numbers AI11202, AI14784, and AI32834 awarded by the National Institutes of Health. The Government has certain rights in the invention.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4843004 |
Platsoucas |
Jun 1989 |
|
4946788 |
Delespesse |
Aug 1990 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
285 405 |
Mar 1988 |
EPX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
061,041 |
May 1993 |
|
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
PCT/US92/04614 |
Jun 1992 |
|
Parent |
709,375 |
Jun 1991 |
|
Parent |
533,889 |
Jun 1990 |
|